Doximity Investor Presentation Deck

THE DIGITAL PLATFORM FOR DOCTORS Leading Network Blue Chip Clients 80%+ 20/20 66% Top Hospitals Revenue Growth5 of all U.S. Physicians¹ and Health Systems Top Pharmaceutical Manufacturers³ Growth and Profit 350K+ 157% 44% Net Revenue Retention Rate 4,5 Adj. EBITDA Margin 5.6 Telehealth Unique Active Providers² doximity 5:47 d The Lancet Respiratory Medicine 1d B Atypical Presentation of COVID-19 in a 34 Year- Old Man 22min read-CME The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenges 15 Comments Natalia Birgisson, MD Resident Physician 0 61 I was struck by the multiple possible etiologies explaining his course, and what a reminder more 34-Reply u Add a comment more Anupam Jena, MD your colleague was published 1d Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare.... Psychiatric services (Washington, DC.) Q Home 1. As of 3/31/22. 2. For fiscal quarter ending 3/31/22. 3. Top 20 Pharmaceutical Manufacturers based on data from FiercePharma, Top 20 hospitals based on U.S. News & World Report's Best Hospitals 2021-2022 Rankings. 4. Net revenue retention rate (NRR) is calculated by taking the TTM subscription-based revenue from our customers that had revenue in the prior TTM period and dividing by the total subscription-based revenue for the prior TTM period. 5. For the trailing twelve month (TTM) period ending 3/31/22. 6. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, and other (income) expense, net. Adjusted EBITDA Margin represents Adjusted EBITDA as a % of revenue. Refer to appendix for the Adjusted EBITDA non-GAAP reconciliation. Proprietary 3

View entire presentation